263 related articles for article (PubMed ID: 22462697)
1. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review.
Smith ER; Scott RM
J Neurosurg Pediatr; 2012 Apr; 9(4):353-60. PubMed ID: 22462697
[TBL] [Abstract][Full Text] [Related]
2. Cerebral blood flow in children with spontaneous occlusion of the circle of Willis (moyamoya disease): comparison with healthy children and evaluation of annual changes.
Kuroda S; Kamiyama H; Abe H; Yamauchi T; Kohama Y; Houkin K; Mitsumori K
Neurol Med Chir (Tokyo); 1993 Jul; 33(7):434-8. PubMed ID: 7692320
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.
Fukui M
Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S238-40. PubMed ID: 9409446
[No Abstract] [Full Text] [Related]
4. Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization.
Jernigan S; Storey A; Hammer C; Riordan C; Orbach DB; Scott RM; Smith E
J Neurosurg Pediatr; 2019 Feb; 23(4):493-497. PubMed ID: 30717056
[TBL] [Abstract][Full Text] [Related]
5. Rational approach to treatment of moyamoya disease in childhood.
Ikezaki K
J Child Neurol; 2000 May; 15(5):350-6. PubMed ID: 10830202
[TBL] [Abstract][Full Text] [Related]
6. Modified encephaloduroarteriosynangiosis as a surgical treatment of childhood moyamoya disease: report of five cases.
Rooney CM; Kaye EM; Scott RM; Klucznik RP; Rosman NP
J Child Neurol; 1991 Jan; 6(1):24-31. PubMed ID: 2002197
[TBL] [Abstract][Full Text] [Related]
7. [Moyamoya disease: advantage of early diagnosis and survival treatment. Review of three cases].
Morel C; Rousselle C; Pelissou-Guyotat I; Begey-Scherrer V; Mamelle JC; Deruty R
Arch Pediatr; 1999 Nov; 6(11):1186-90. PubMed ID: 10587742
[TBL] [Abstract][Full Text] [Related]
8. Use of a calcium channel blocker (nicardipine HCl) in the treatment of childhood moyamoya disease.
Hosain SA; Hughes JT; Forem SL; Wisoff J; Fish I
J Child Neurol; 1994 Oct; 9(4):378-80. PubMed ID: 7822727
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya disease showing atypical angiographic findings--two case reports.
Kataoka H; Miyamoto S; Nagata I; Hatano T; Kano H; Hashimoto N
Neurol Med Chir (Tokyo); 1999 Apr; 39(4):294-8. PubMed ID: 10358984
[TBL] [Abstract][Full Text] [Related]
10. [A case of adult moyamoya disease showing fulminant clinical course associated with progression from unilateral to bilateral involvement].
Fujiwara F; Yamada H; Hayashi S; Tamaki N
No Shinkei Geka; 1997 Jan; 25(1):79-84. PubMed ID: 8990473
[TBL] [Abstract][Full Text] [Related]
11. Regression of moyamoya vessels and hemodynamic changes after successful revascularization in childhood moyamoya disease.
Kashiwagi S; Yamashita T; Katoh S; Kitahara T; Nakashima K; Yasuhara S; Ito H
Acta Neurol Scand Suppl; 1996; 166():85-8. PubMed ID: 8686450
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset.
Yamamoto S; Hori S; Kashiwazaki D; Akioka N; Kuwayama N; Kuroda S
J Neurosurg; 2018 Mar; 130(3):884-890. PubMed ID: 29570010
[TBL] [Abstract][Full Text] [Related]
13. Dural inversion procedure for moyamoya disease. Technical note.
Dauser RC; Tuite GF; McCluggage CW
J Neurosurg; 1997 Apr; 86(4):719-23. PubMed ID: 9120639
[TBL] [Abstract][Full Text] [Related]
14. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease.
Iwama T; Hashimoto N; Yonekawa Y
Neurosurgery; 1996 Jun; 38(6):1120-5; discussion 1125-6. PubMed ID: 8727141
[TBL] [Abstract][Full Text] [Related]
15. Children with unilateral occlusion or stenosis of the ICA associated with surrounding moyamoya vessels--"unilateral" moyamoya disease.
Matsushima T; Inoue T; Natori Y; Fujii K; Fukui M; Hasuo K; Kuwabara Y
Acta Neurochir (Wien); 1994; 131(3-4):196-202. PubMed ID: 7754820
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms.
Matsushima Y; Inaba Y
Childs Brain; 1984; 11(3):155-70. PubMed ID: 6723433
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus associated with moyamoya syndrome.
El Ramahi KM; Al Rayes HM
Lupus; 2000; 9(8):632-6. PubMed ID: 11035439
[TBL] [Abstract][Full Text] [Related]
18. Frontal lobe infarction due to hemodynamic change after surgical revascularization in moyamoya disease--two case reports.
Kuroda S; Houkin K; Nunomura M; Abe H
Neurol Med Chir (Tokyo); 2000 Jun; 40(6):315-20. PubMed ID: 10892268
[TBL] [Abstract][Full Text] [Related]
19. Postoperative neurological deterioration following the revascularization surgery in children with moyamoya disease.
Sakamoto T; Kawaguchi M; Kurehara K; Kitaguchi K; Furuya H; Karasawa J
J Neurosurg Anesthesiol; 1998 Jan; 10(1):37-41. PubMed ID: 9438618
[TBL] [Abstract][Full Text] [Related]
20. Moyamoya disease in children. A review of the clinical and radiological features and current treatment.
Manceau E; Giroud M; Dumas R
Childs Nerv Syst; 1997; 13(11-12):595-600. PubMed ID: 9454975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
